ArticleBioengineering & translational medicine2023

Splice-switch oligonucleotide-based combinatorial platform prioritizes synthetic lethal targets CHK1 and BRD4 against MYC-driven hepatocellular carcinoma.

Dexter Kai Hao Thng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.